• Hoechst 33342 for TNT Transport Imaging

  2026-09-01

  Hoechst 33342 adds a fast, live-cell nuclear reference to advanced tunneling nanotube transport experiments without replacing cargo-specific or force-sensitive readouts. This workflow shows how to combine nuclear segmentation, chromatin morphology, and cell-state controls with lipid-droplet tracking and optical trapping.

• Dabigatran: From Thrombin Mechanism to Translation

  2026-08-31

  Dabigatran and Pradaxa provide a precise framework for studying thrombin-driven coagulation. This thought-leadership guide connects direct thrombin inhibition with catalpol’s broader cardio-cerebrovascular biology, offering translational researchers practical assay strategy, metabolite-aware interpretation, and a disciplined path from in vitro findings to clinically relevant questions.

• 25-Hydroxycholesterol, AMPK, and TAM Reprogramming

  2026-08-30

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that activates lysosomal AMPKα and reinforces STAT6-dependent immunosuppression in tumor-associated macrophages. The study connects oxysterol storage, GPR155–mTORC1 signaling, macrophage metabolism, and T-cell exclusion, while showing that CH25H targeting can improve antitumor responses to PD-1 blockade.

• Sodium Ascorbate ROS Assays in Cancer Research

  2026-08-29

  Sodium Ascorbate enables solvent-controlled studies of intracellular oxidative stress, tumor-cell injury, proliferation, and motility. This practical workflow also shows how ROS phenotyping can be paired cautiously with biomarker concepts from GPNMB-based immunotherapy research without overstating translational evidence.

• EdU Imaging Kits (HF488) for Cell Proliferation

  2026-08-29

  EdU Imaging Kits (HF488) use 5-ethynyl-2'-deoxyuridine incorporation and click chemistry to measure DNA synthesis during S phase. The K2240 workflow supports fluorescence microscopy and flow cytometry with a fluorescent HyperFluor™ 488 readout and avoids the DNA-denaturation step used in conventional BrdU detection.

• Engineering the Cas9 mRNA Window for Precision

  2026-08-28

  Precision genome editing depends not only on guide design and nuclease fidelity, but also on how long Cas9 is translated, where its mRNA travels, and how the innate immune system responds. This thought-leadership article connects Cap1 capping, N1-Methylpseudo-UTP modification, poly(A) tailing, and nuclear-export control to practical CRISPR-Cas9 workflow design. It also explains where EZ Cap™ Cas9 mRNA (m1Ψ) fits, how to benchmark it responsibly, and why transient mRNA control is strategically important for translational researchers.

• Direct Mouse Genotyping Kit for GEMM Assays

  2026-08-28

  The Direct Mouse Genotyping Kit simplifies PCR amplification from mouse tissue for genetically engineered mesothelioma models. This guide explains how to align direct lysate PCR with allele design, conditional recombination, quality control, and high-throughput mouse genetic screening.

• Telmisartan in Angiotensin II Cardiac Research

  2026-08-27

  Telmisartan is an angiotensin II receptor antagonist used as an AT1-receptor perturbation tool in hypertension research compound workflows. Its defined chemical profile and DMSO compatibility support cardiovascular disease research, while RIP3/CaMKII findings from an isochlorogenic acid A study should not be attributed directly to telmisartan.

• Recombinant Annexin V for Apoptosis Detection

  2026-08-27

  Brumatti, Sheridan, and Martin established a practical bacterial expression, purification, and FITC-labeling workflow for recombinant annexin V. The study shows how a soluble polyhistidine-tagged protein can provide a reproducible probe for phosphatidylserine exposure in apoptotic cells, with applications in flow cytometry and fluorescence microscopy.

• TBST Workflows for Clearer Immunoassay Signals

  2026-08-26

  TBST supports reproducible blocking, antibody dilution, and washing across Western blot, immunofluorescence, immunohistochemistry, and immunocytochemistry workflows. This guide connects its detergent-controlled assay role with a published uPAR·uPA inhibitor study, showing how disciplined washing and background control can strengthen mechanistic readouts without overstating what the buffer proves.

• Carbenoxolone disodium: Workflow and QC Guide

  2026-08-26

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled cell- and tissue-based studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is suitable for mechanistic workflows with solvent, viability, and pathway controls, but should not be treated as a selective in vivo efficacy agent or a validated treatment for disease models.

• Cy7 NHS Ester: Practical Labeling and QC Guide

  2026-08-25

  Cy7 NHS ester (A8109) is a water-soluble, sulfonated protein labeling dye for attaching near-infrared fluorescence to primary amino groups in proteins and peptides. It is suited to aqueous biomolecule conjugation and near-infrared fluorescent imaging, but prepared solutions should be used promptly and labeling conditions must be optimized for each target.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-08-25

  This 2015 study describes indazole- and indole-based glucagon receptor antagonists derived from the MK-0893 design concept. Its integrated scaffold optimization, structure–activity relationship analysis, pharmacokinetic testing, and acute humanized-mouse studies identified compounds with promising early pharmacological profiles, including orally active GRA 16d.

• Ionomycin Free Acid as a Calcium Causality Probe

  2026-08-24

  Ionomycin free acid is a calcium ionophore for controlled intracellular calcium increase and mechanistic cell biology. This article explains how to use it as a causal probe for the FAISL–FAK–calpain axis in triple-negative breast cancer research while separating established findings from testable hypotheses.

• AZD3463 Workflow for ALK/IGF1R Studies

  2026-08-23

  Build reproducible neuroblastoma experiments around AZD3463 by linking ALK/IGF1R blockade to PI3K/AKT/mTOR signaling, apoptosis, autophagy, and chemotherapy response. The workflow also shows how a breast-cancer pathway study can inspire carefully bounded assay extensions without overstating cross-model evidence.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page